Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Recruitment Status

Not yet recruiting clinical trials

Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 9:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials
3240
Shown on this page
12
Current sort
Recently updated
Status scope
Not yet recruiting
Additional filters apply within this recruitment status.

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

Filter and sort this status page

These controls apply only within Not yet recruiting. Default order is Recently updated. Add condition, location, sponsor, or therapy filters to narrow this status page further.

Reset status filters
Clear filters
Showing 445–456 of 3,240 matching trials with status Not yet recruiting.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.

Live official records

Open in full search
Not yet recruiting Phase 4 Interventional

Azithromycin for Cerclage Prophylaxis

NCT07608562
View directory record Official record
Conditions
Cervical Insufficiency
Interventions
Azithromycin Prophylaxis, Azithromycin Placebo, Cefazolin, Progesterone
Drug
Lead sponsor
Wake Forest University Health Sciences
Other
Eligibility
18 Years and older · Female only
Enrollment
80 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
2
States / cities
Oak Lawn, Illinois • Park Ridge, Illinois
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional Accepts healthy volunteers

Quit and Screen Project

NCT06350643
View directory record Official record
Conditions
Knowledge, Attitudes, Behavioral Intention
Interventions
Quit and Screen Project training, G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
Other
Lead sponsor
University of Arkansas
Other
Eligibility
21 Years to 85 Years
Enrollment
300 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2027
U.S. locations
1
States / cities
Richmond, Virginia
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional

HERE: Health Empowerment and Resources After Pregnancy

NCT07701148
View directory record Official record
Conditions
Cardiovascular Health
Interventions
Longitudinal patient navigation, Standard care
Other
Lead sponsor
Boston Medical Center
Other
Eligibility
23 Years and older · Female only
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting No phase listed Observational

Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood

NCT07493720
View directory record Official record
Conditions
Pregnancy
Interventions
Beta-hCG
Diagnostic Test
Lead sponsor
University of Nebraska
Other
Eligibility
19 Years and older · Female only
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026
U.S. locations
1
States / cities
Omaha, Nebraska
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting No phase listed Observational

Phase 1: Thrive Together

NCT07894094
View directory record Official record
Conditions
Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions
Not listed
Lead sponsor
Boston Children's Hospital
Other
Eligibility
13 Years to 18 Years
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
1
States / cities
Brookline, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Phase 1 Interventional

Daraxonrasib in Resectable PDAC

NCT07898813
View directory record Official record
Conditions
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Resectable Pancreatic Ductal Adenocarcinoma
Interventions
Daraxonrasib, Surgical Resection, Adjuvant Chemotherapy, Adjuvant Radiation Therapy
Drug · Procedure · Radiation
Lead sponsor
Dana-Farber Cancer Institute
Other
Eligibility
18 Years and older
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2029
U.S. locations
2
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional

Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function

NCT07414810
View directory record Official record
Conditions
Cystic Fibrosis
Interventions
micro Sweat Test Patch (mSTP), Sweat Testing using SOC
Device · Diagnostic Test
Lead sponsor
Emory University
Other
Eligibility
2 Weeks to 90 Years
Enrollment
300 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
2
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Phase 1Phase 2 Interventional

DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers

NCT07707895
View directory record Official record
Conditions
Small Cell Lung Cancer, Large Cell Neuroendocrine Lung Carcinoma, Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
Interventions
Obrixtamig, ZL-1310, Atezolizumab
Drug
Lead sponsor
Boehringer Ingelheim
Industry
Eligibility
18 Years and older
Enrollment
60 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
3
States / cities
Washington D.C., District of Columbia • Tampa, Florida • Lexington, Kentucky
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional Accepts healthy volunteers

Comparison Between Eccentric Hamstring Training and Sprint-Specific Training

NCT07716319
View directory record Official record
Conditions
Healthy Adult, Athlete, Exercise Training, Sport, Running, Ultrasound Imaging
Interventions
RDL, NHE, Sprint testing
Other
Lead sponsor
University of Wisconsin, Madison
Other
Eligibility
18 Years to 25 Years
Enrollment
90 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026 – 2027
U.S. locations
1
States / cities
Madison, Wisconsin
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional

Wearable Ankle Power Training (WearAPT) for Enhanced Mobility in Aging

NCT07897461
View directory record Official record
Conditions
Sedentary Behavior / Physical Inactivity, Aged
Interventions
Wearable Ankle Power Training (WearAPT), Control
Other
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
60 Years and older
Enrollment
72 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2030
U.S. locations
2
States / cities
Flagstaff, Arizona • Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Phase 4 Interventional

Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease

NCT07187466
View directory record Official record
Conditions
Overactive Bladder, Parkinson Disease
Interventions
mirabegron, Exercise-based behavioral therapy
Drug · Behavioral
Lead sponsor
VA Office of Research and Development
Federal
Eligibility
18 Years and older
Enrollment
146 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2030
U.S. locations
3
States / cities
Decatur, Georgia • Philadelphia, Pennsylvania • Salt Lake City, Utah
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST
Not yet recruiting Not applicable Interventional

Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors

NCT07898241
View directory record Official record
Conditions
Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung
Interventions
Artificial Intelligence-based Intervention, Best Practice, Computed Tomography, Positron Emission Tomography, Radiology, Treatment Planning, Stereotactic Body Radiation Therapy, Survey Administration
Other · Procedure · Radiation
Lead sponsor
Northwestern University
Other
Eligibility
18 Years and older
Enrollment
34 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2027 – 2032
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Oct 27, 2026 · Synced Nov 9, 2026, 9:56 AM EST